This scoring system evaluates the immune status of the tumor based on the presence of Th1 and cytotoxic CD8 T cells, along with the expression of immune checkpoints and inflammatory and cytotoxic cytokines associated with T cells. The gene discussed is CD8A; the disease is neoplasm.